GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avax Technologies Inc (OTCPK:AVXT) » Definitions » Operating Margin %

Avax Technologies (Avax Technologies) Operating Margin % : -939.00% (As of Sep. 2008)


View and export this data going back to . Start your Free Trial

What is Avax Technologies Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Avax Technologies's Operating Income for the three months ended in Sep. 2008 was $-1.88 Mil. Avax Technologies's Revenue for the three months ended in Sep. 2008 was $0.20 Mil. Therefore, Avax Technologies's Operating Margin % for the quarter that ended in Sep. 2008 was -939.00%.

The historical rank and industry rank for Avax Technologies's Operating Margin % or its related term are showing as below:


AVXT's Operating Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -155.18
* Ranked among companies with meaningful Operating Margin % only.

Avax Technologies's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Avax Technologies's Operating Income for the three months ended in Sep. 2008 was $-1.88 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Sep. 2008 was $-7.52 Mil.


Avax Technologies Operating Margin % Historical Data

The historical data trend for Avax Technologies's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avax Technologies Operating Margin % Chart

Avax Technologies Annual Data
Trend Dec98 Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -350.59 -197.52 -236.76 -748.16 -1,084.76

Avax Technologies Quarterly Data
Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,056.25 -558.49 -1,645.83 -1,964.58 -939.00

Competitive Comparison of Avax Technologies's Operating Margin %

For the Biotechnology subindustry, Avax Technologies's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avax Technologies's Operating Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avax Technologies's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Avax Technologies's Operating Margin % falls into.



Avax Technologies Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Avax Technologies's Operating Margin % for the fiscal year that ended in Dec. 2007 is calculated as

Operating Margin %=Operating Income (A: Dec. 2007 ) / Revenue (A: Dec. 2007 )
=-6.693 / 0.617
=-1,084.76 %

Avax Technologies's Operating Margin % for the quarter that ended in Sep. 2008 is calculated as

Operating Margin %=Operating Income (Q: Sep. 2008 ) / Revenue (Q: Sep. 2008 )
=-1.878 / 0.2
=-939.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avax Technologies  (OTCPK:AVXT) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Avax Technologies Operating Margin % Related Terms

Thank you for viewing the detailed overview of Avax Technologies's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Avax Technologies (Avax Technologies) Business Description

Traded in Other Exchanges
N/A
Address
9200 Indian Creek Parkway, Suite 200, Overland Park, KS, USA, 66210
Avax Technologies Inc is a development stage biotechnology company. The company is engaged in the development and commercialization of individualized vaccine therapies and other technologies for the treatment of cancer. It also involved in the development and commercial readiness in the immuno-oncology arena.
Executives
Carl Spana director PALATIN TECHNOLOGIES, INC., 4B CEDAR BROOK DRIVE, CRANBURY NJ 08512
Prendergast John K A director ROBERTS SHERIDAN & KOTEL, 12 EAST 49TH STREET 30TH FL, NEW YORK NY 10017

Avax Technologies (Avax Technologies) Headlines

No Headlines